Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Winston

Showing results (271-280 of 290) with videos related to

Pageof 29
Sort By:
Neurosurgery|November 11, 2025
Predictors of Kyphoplasty Failures Requiring Surgical Stabilization in Patients With Cancer With Pathological Vertebral Body FracturesGraham M Winston, Rabih Bou Nassif, William C Newman, et al.
Nature Neuroscience|March 12, 2026
Deconstruction of a memory engram reveals distinct ensembles recruited at learningClément Pouget, Flora Morier, Livia Autore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2014
Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor modelsKristan Meetze, Sylvie Vincent, Steven Tyler, et al.
Human Gene Therapy|February 29, 2024
Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene TransferMark A Brimble, Christopher L Morton, Stephen M Winston, et al.
Pharmacology, Biochemistry, and Behavior|April 18, 2006
Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387Peter J McLaughlin, Liu Qian, JodiAnne T Wood, et al.
Cancer Immunology Research|March 14, 2022
Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor RegressionChristopher J Nirschl, Heather R Brodkin, Daniel J Hicklin, et al.
Journal of Chromatography. A|December 9, 2004
Choosing an equivalent replacement column for a reversed-phase liquid chromatographic assay procedureJ W Dolan, A Maule, D Bingley, et al.
Molecular Cancer Therapeutics|May 22, 2015
23814, an Inhibitory Antibody of Ligand-Mediated Notch1 Activation, Modulates Angiogenesis and Inhibits Tumor Growth without Gastrointestinal ToxicityTheresa Proia, Feng Jiang, Alisa Bell, et al.
Cancer Immunology Research|April 19, 2023
mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor ImmunityChristopher J Nirschl, Heather R Brodkin, Celesztina Domonkos, et al.
World Neurosurgery|March 27, 2021
Neurosurgery in COVID-19 Ground Zero: The Weill Cornell Medicine ExperienceGraham M Winston, Andrew L A Garton, John K Chae, et al.
Pageof 29

Showing results (271-280 of 290) with videos related to

Sort By:
Pageof 29
Neurosurgery|November 11, 2025
Predictors of Kyphoplasty Failures Requiring Surgical Stabilization in Patients With Cancer With Pathological Vertebral Body FracturesGraham M Winston, Rabih Bou Nassif, William C Newman, et al.
Nature Neuroscience|March 12, 2026
Deconstruction of a memory engram reveals distinct ensembles recruited at learningClément Pouget, Flora Morier, Livia Autore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2014
Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor modelsKristan Meetze, Sylvie Vincent, Steven Tyler, et al.
Human Gene Therapy|February 29, 2024
Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene TransferMark A Brimble, Christopher L Morton, Stephen M Winston, et al.
Pharmacology, Biochemistry, and Behavior|April 18, 2006
Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387Peter J McLaughlin, Liu Qian, JodiAnne T Wood, et al.
Cancer Immunology Research|March 14, 2022
Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor RegressionChristopher J Nirschl, Heather R Brodkin, Daniel J Hicklin, et al.
Journal of Chromatography. A|December 9, 2004
Choosing an equivalent replacement column for a reversed-phase liquid chromatographic assay procedureJ W Dolan, A Maule, D Bingley, et al.
Molecular Cancer Therapeutics|May 22, 2015
23814, an Inhibitory Antibody of Ligand-Mediated Notch1 Activation, Modulates Angiogenesis and Inhibits Tumor Growth without Gastrointestinal ToxicityTheresa Proia, Feng Jiang, Alisa Bell, et al.
Cancer Immunology Research|April 19, 2023
mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor ImmunityChristopher J Nirschl, Heather R Brodkin, Celesztina Domonkos, et al.
World Neurosurgery|March 27, 2021
Neurosurgery in COVID-19 Ground Zero: The Weill Cornell Medicine ExperienceGraham M Winston, Andrew L A Garton, John K Chae, et al.
Pageof 29